DuPont Expands Biopharma Offerings with New Ultra-Low Temperature Tubing
1. Introduction of Liveo™ Pharma TPE Ultra-Low Temp Tubing
In a significant step forward for the biopharmaceutical industry, DuPont de Nemours, Inc. (NYSE: DD) has unveiled its latest innovation: the Liveo™ Pharma TPE Ultra-Low Temp Tubing. This newly developed thermoplastic elastomer (TPE) tubing is specially designed to meet the stringent low-temperature requirements essential for various biopharmaceutical processing applications. The announcement was made on April 1, 2025, emphasizing DuPont’s commitment to advancing healthcare technologies.
2. Key Features and Benefits
The Liveo™ Pharma TPE Ultra-Low Temp Tubing boasts a number of impressive features that set it apart in the competitive market:
- Temperature Resilience: The tubing maintains toughness and ductility down to -86 °C, ensuring reliability in extreme conditions.
- Physical Durability: It exhibits resistance to bend, crush, and impact at temperatures as low as -80 °C, making it suitable for rigorous biopharma applications.
- Regulatory Compliance: The tubing meets various high-purity standards, including USP Class VI, extractables USP <665>, elemental impurities USP <232>, and ISO 10993 for biocompatibility, which are critical for the manufacturing and handling of biopharmaceutical products.
- Performance Attributes: It offers excellent pumpability, low spallation rates, and remarkable burst pressure resistance, enhancing its functionality in fluid transport and single-use bioprocessing applications.
Diana Salvadori, DuPont's Global Senior Product Marketing Manager for Biopharma Processing, highlighted the increasing demand for high-purity materials in the industry. She stated, “With our new Liveo™ Pharma TPE Ultra-Low Temp Tubing, DuPont is offering an additional thermoplastic elastomer tubing option for fluid transport and single-use bioprocessing applications, facilitating adoption and compatibility with alternative TPE tubing offerings.”
3. Expanding the Product Portfolio
The launch of the Ultra-Low Temp Tubing marks DuPont's second TPE tubing product in recent years, complementing the existing Liveo™ Pharma TPE Tubing. This expansion aligns with DuPont's broader portfolio of solutions aimed at the biopharma processing sector, which also includes a range of silicone-based tubing and overmolded assembly (OMA) products. Salvadori noted that DuPont's TPE tubing is produced under the same rigorous quality principles as their trusted silicone-based products, reassuring customers of their reliability and efficacy.
4. Commitment to Healthcare Innovation
DuPont™ Liveo™ is recognized globally for its innovative technologies across a wide spectrum of healthcare solutions, including medical devices, biopharmaceutical processing, and pharmaceutical solutions. The company’s high-performance materials are designed to create safer healthcare environments, ultimately protecting the health of patients and healthcare providers alike.
For more information about the Liveo™ Pharma TPE Ultra-Low Temp Tubing and its comprehensive features and benefits, interested parties are encouraged to access the product brochure available at liveo.dupont.com.
5. Conclusion
With its latest offering, DuPont reaffirms its position as a leader in the biopharmaceutical industry by addressing the critical need for durable, low-temperature tubing solutions. The introduction of the Liveo™ Pharma TPE Ultra-Low Temp Tubing is expected to facilitate advancements in biopharmaceutical processing, contributing to improved patient outcomes and healthcare solutions worldwide. As DuPont continues to innovate, stakeholders in the biopharma sector can look forward to enhanced product offerings that meet their evolving needs.
